NexgenRx's total assets for Q3 2024 were $31.59M, an increase of 3.13% from the previous quarter. TSE:NXG total liabilities were $23.49M for the fiscal quarter, a 3.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.